Amy Glison was called the acting administrator Dog, but no one knows what she actually does. The White House made this announcement, but when he was pressed on the details, the officials had nothing.
Meanwhile, Elon Musk, who is simply a special civil servant, is still called responsible. Even Donald Trump called Doga “led by Elon Musk”, raising new legal questions about who really runs the agency.
A few weeks passed before the administration even confirmed the role of Amy. Lawyers representing the White House could not answer who actually answered, and only after they were put in place, the name of the AMI administration as an acting administrator.
Since then, she has not made any public statements, and neither DOG nor the White House gave a real understanding of what is happening inside the agency. Elon constantly puts forward the idea of transparency, but the dog works in the dark.
If Amy should be the leading rain, Elon does not behave like that. The billionaire still controls the direction of the agency, despite the fact that he technically does not hold the highest work.
His special status of a civil servant allows him to participate without official responsibility, which allows him to circumvent many rules that are usually applied to someone in his position.
The silence of the White House for this only nourishes speculation. If Amy heads the agency, why does it not answer questions? If Elon is not so, why does Trump continue to say that he is?
“This is exactly the person that you need in such a role,” said Dr. Gregg Alexander, a pediatrician in London, Ohio, who knows Amy for about 20 years. But although some believe in her ability, others are worried that she may unconsciously facilitate the reduction of the budget of federal health programs, which she once supported.
Amy’s past in the field of healthcare and government technologies
Amy spent years in the field of healthcare. She began as a nurse ER, but when her daughter, Morgan, began to demonstrate inexplicable muscle weakness and rash, she realized that the system was not created to properly monitor complex cases. It took more than a year to make a diagnosis: juvenile dermatomyositis, a rare autoimmune disease.
This experience was pushed by Amy in health data technology. She became a co -founder of Caresync, a company that worked on the management of medical cards, and then joined the American digital service, the agency in the administrations of Trump and Biden. She worked on electronic medical cards and pandemic data, and helped improve healthcare tracking tools.
“If the doctor had seen all these visits and activity on one screen that gathered, they probably would ask the question of why this 10- or 11-year-old child all the time goes to the doctor,” Amy said in the TEDX 2020 conversation.
From 2021 to 2024, she held enforcement posts at Main Street Health and Russell Street Ventures, two startups oriented to health. Communication with the Russian Street Ventures is noticeable because its founder, Brad Smith, was the early Doge insider and a key figure in the plans to reduce Elon’s expenses for the agency.
The potential influence of the Doga on health financing
Now Amy is in a position that can affect the programs for which she once fought. DOGE offers the main reduction in the budget for centers for the control and prevention of diseases (CDC) and National Health Institutes (NIH), both of which finance research for rare diseases, such as her daughter.
James Minow, Executive Director of Foundation Cure JM, where Amy was once a member of the board of directors, said that the bets were high. “Obviously, Cure JM wants to do everything possible to protect NIH investments.”
Despite the fact that Amy is now described as an apolitical, it now works inside an agency, which is openly striving to reduce the government. Some of her former colleagues say that they were shocked by her appointment. One of the health care workers, who knew Amy for 15 years, said: “The transition from such a position of kindness to a position that eliminates jobs for thousands of working parents seems to be such a dichotomy in values.”
Her career has always been about the effectiveness of healthcare, but now she leads an agency that can reduce vital research. It is unclear whether it is actually the right to vote, or is Elon, who makes real calls, remains unclear. The only thing that is for sure is that Dog does not answer any questions.
